Menu
A global tech-enabled health company based in the Middle East asked our help to maximize the value they could derive from their genomic and clinical datasets, as well as other assets.
The health company possesses several advantages including access to linked genomic and clinical data, an in-house CRO, direct healthcare provider access, and in-house AI capabilities, but needed support aligning and optimizing these elements.
We helped them develop a comprehensive commercialization strategy and prioritized action plan for monetizing the dataset and positioning the company to move up the value chain from data provider to precision medicine-oriented pharma.
A global tech-enabled health company based in the Middle East asked our help to maximize the value they could derive from their genomic and clinical datasets and other assets.
The health company possesses several advantages including access to linked genomic and clinical data, an in-house CRO, direct healthcare provider access, and in-house AI capabilities, but needed support aligning and optimizing these elements.
We helped them develop a comprehensive commercialization strategy and prioritized action plan for monetizing the dataset and positioning the company to move up the value chain from data provider to precision medicine-oriented pharma.
For additional information please email us at: info@xeomics.com